Menahydroquinone-4 Prodrug: A Promising Candidate Anti-Hepatocellular Carcinoma Agent

Recently, new therapeutics have been developed for hepatocellular carcinoma (HCC). However, the overall survival rate of HCC patients is still unsatisfactory; one of the reasons for this is the high frequency of recurrence after radical treatment. Consequently, to improve prognosis, it will be impor...

Full description

Saved in:
Bibliographic Details
Published in:Diseases
Main Authors: Enjoji, Munechika, Watase, Daisuke, Matsunaga, Kazuhisa, Kusuda, Mariko, Nagata-Akaho, Nami, Karube, Yoshiharu, Takata, Jiro
Format: Artigo
Language:Inglês
Published: MDPI 2015
Subjects:
Review
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5548248/
https://ncbi.nlm.nih.gov/pubmed/28943616
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/diseases3030150
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items